Trial intelligence / Profile preview

Impact of Injected Volume on Programmed Intermittent Epidural Bolus Analgesia

NCT07684365Phase 4Not yet recruiting

Sponsor
Beth Israel Deaconess Medical Center
Start
Oct 2026
Primary completion
Dec 2027
01

Overview

A Phase 4 trial of bupivacaine, fentanyl in labor pain, sponsored by Beth Israel Deaconess Medical Center. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

bupivacainefentanyl
03

Conditions

labor pain

Beyond the preview

Go deeper on NCT07684365.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07684365.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call